4//SEC Filing
Morley Stephanie 4
Accession 0000905718-18-000355
CIK 0001684144other
Filed
Mar 29, 8:00 PM ET
Accepted
Mar 30, 4:08 PM ET
Size
10.5 KB
Accession
0000905718-18-000355
Insider Transaction Report
Form 4
Morley Stephanie
COO & VP of Product Dev
Transactions
- Exercise/Conversion
Common Shares, without par value
2018-03-29$0.20/sh+500,000$100,000→ 1,355,580 total - Exercise/Conversion
Stock Option (right to buy)
2018-03-29−500,000→ 600,000 totalExercise: $0.20From: 2016-03-28Exp: 2018-04-21→ Common Shares, without par value (500,000 underlying)
Holdings
- 1,000(indirect: By daughter)
Common Shares, without par value
- 1,000(indirect: By step-daughter)
Common Shares, without par value
- 1,000(indirect: By step-son)
Common Shares, without par value
- 1,000(indirect: By daughter)
Common Shares, without par value
- 1,000(indirect: By step-son)
Common Shares, without par value
Footnotes (1)
- [F1]The options vested upon grant. The option is currently fully vested.
Documents
Issuer
Zomedica Pharmaceuticals Corp.
CIK 0001684144
Entity typeother
Related Parties
1- filerCIK 0001721793
Filing Metadata
- Form type
- 4
- Filed
- Mar 29, 8:00 PM ET
- Accepted
- Mar 30, 4:08 PM ET
- Size
- 10.5 KB